Terns Pharmaceuticals Stock Quote TERN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.65

Bid

6.50

Ask

6.65

Volume

1,489,166

6.38 Day's Range 7.25

3.26 52 Week Range 10.67

Market Cap

430.75M

Previous Close

7.25

Open

7.25

Last Trade

2000

6.65

(formt)

Last Trade Time

Financial Volume

$ 9,857,695

VWAP

6.6196

Average Volume (3m)

976,325

Shares Outstanding

64,677,145

Dividend Yield

PE Ratio

-4.77

Earnings Per Share (EPS)

-1.39

Revenue

Net Profit

-90.21M

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ternspharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Terns Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TERN. The last closing price for Terns Pharmaceuticals was $7.25. Over the last year, Terns Pharmaceuticals shares have traded in a share price range of $ 3.26 to $ 10.67.

Terns Pharmaceuticals currently has 64,677,145 shares outstanding. The market capitalization of Terns Pharmaceuticals is $430.75 million. Terns Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.77.

Overall Flow

Bullish

Net Premium

331k

Calls / Puts

100.00%

Buys / Sells

60.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation

FOSTER CITY, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.68	-9.27694406548	7.33	8	6.38	1096125	7.30869915	CS
4	0.46	7.43134087237	6.19	8.415	5.715	1371877	7.1558497	CS
12	0.12	1.83767228178	6.53	8.415	4.32	976325	6.24972157	CS
26	0.03	0.453172205438	6.62	8.68	4.32	901794	6.54439437	CS
52	-4.01	-37.617260788	10.66	10.67	3.26	760345	6.44377131	CS
156	-7.01	-51.317715959	13.66	14.0435	1.45	415379	7.04702579	CS
260	-10.3	-60.7669616519	16.95	28.36	1.45	384408	7.66588762	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WENAANEW MEDICAL INC	$ 3.61 (118.79%)	89.77M
CMAXCareMax Inc	$ 3.40 (78.95%)	13.76M
FFIEFaraday Future Intelligent Electric Inc	$ 0.4562 (72.15%)	665.83M
OPTXSyntec Optics Holdings Inc	$ 3.85 (63.83%)	35.43M
MEDSTRxADE HEALTH Inc	$ 11.85 (35.12%)	383.69k
BJDXBluejay Diagnostics Inc	$ 1.6293 (-40.75%)	2.49M
GRIGRI Bio Inc	$ 1.8493 (-37.73%)	774.11k
LYELLyell Immunopharma Inc	$ 1.30 (-36.27%)	11.88M
NUWENewellis Inc	$ 0.1404 (-35.54%)	11.3M
CNSPCNS Pharmaceuticals Inc	$ 1.88 (-33.80%)	1.54M
FFIEFaraday Future Intelligent Electric Inc	$ 0.4562 (72.15%)	665.86M
NVDANVIDIA Corporation	$ 126.40 (0.25%)	362.27M
RIVNRivian Automotive Inc	$ 14.74 (23.24%)	261.97M
SQQQProShares UltraPro Short QQQ	$ 8.18 (-2.50%)	109.66M
TSLATesla Inc	$ 196.37 (4.81%)	95.73M